Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,173.91
(
0.12%
)
US TECH 100
26,569.20
(
0.00%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
104.48
(
2.32%
)
Bitcoin
76,883.06
(
-0.63%
)
News Focus
News Focus
Post# of 257454
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122891
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 253494

Tuesday, 01/14/2025 10:56:50 AM

Tuesday, January 14, 2025 10:56:50 AM

Post# of 257454
LLY—(-6%)—announces 4Q24 sales miss/2025 guidance:

https://www.prnewswire.com/news-releases/lilly-provides-update-on-2024-revenue-guidance-announces-2025-revenue-guidance-302349776.html

For Q4 2024, Lilly now expects worldwide revenue to be approximately $13.5 billion, representing growth of 45% compared to Q4 2023. This includes approximately $3.5 billion for Mounjaro and $1.9 billion for Zepbound.

… the company's expected [full-year] 2024 revenue is $400 million or about 3%, below the guidance range issued on October 30, 2024…

2025 revenue guidance is $58-61B, +29-36% relative to 2024’s $45B.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today